Viking Therapeutics, Inc. (VKTX)
29.39
-0.88
(-2.91%)
USD |
NASDAQ |
May 18, 10:45
Viking Therapeutics Market Cap : 3.412B for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 879.49B |
| Amgen, Inc. | 174.67B |
| Catalyst Pharmaceuticals, Inc. | 3.820B |
| Altimmune, Inc. | 548.42M |
| TG Therapeutics, Inc. | 6.009B |
Market Cap Related Metrics
| PEG Ratio | -0.0273 |
| Price to Book Value | 6.799 |
| Price | 29.39 |
| Earnings Yield | -14.11% |
| PEGY Ratio | -0.0273 |